Compare ETW & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest
Current Price
| Metric | ETW | LMRI |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2005 | 2025 |
| Metric | ETW | LMRI |
|---|---|---|
| Price | $9.84 | $12.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $20.75 |
| AVG Volume (30 Days) | 279.1K | ★ 448.6K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.35 |
| Revenue Next Year | N/A | $5.61 |
| P/E Ratio | ★ N/A | $237.80 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.46 | $6.45 |
| 52 Week High | $9.95 | $19.45 |
| Indicator | ETW | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 57.50 | 54.82 |
| Support Level | $9.74 | $10.09 |
| Resistance Level | $9.91 | $12.81 |
| Average True Range (ATR) | 0.07 | 0.56 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 54.52 | 44.71 |
Eaton Vance Tax-mangd Glo Buy-write Oppo is a United States-based diversified, closed-end management investment company. The primary investment objective of the company is to provide current income and gains. The secondary objective of the fund is capital appreciation. The fund invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of capital markets, chemicals, banks, biotechnology, media, and other sectors.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.